His main research concerns Public health, Substance abuse, Acquired immunodeficiency syndrome, Psychiatry and Cohort. The various areas that Thomas Kerr examines in his Public health study include Family medicine, SAFER, Drug and Environmental health. His biological study spans a wide range of topics, including Internal medicine, Pharmacotherapy, Suicide prevention and Immunology.
His work in Psychiatry addresses issues such as Epidemiology, which are connected to fields such as Injection drug use. His Cohort research incorporates elements of Odds ratio, Cohort study, Heroin, Demography and Emergency medicine. His Cohort study research is multidisciplinary, relying on both Methadone, Prospective cohort study and Gee.
Psychiatry, Prospective cohort study, Odds ratio, Cohort and Public health are his primary areas of study. As a part of the same scientific study, Thomas Kerr usually deals with the Psychiatry, concentrating on Acquired immunodeficiency syndrome and frequently concerns with Immunology. His work deals with themes such as Demography, Proportional hazards model, Cohort study and Hazard ratio, which intersect with Prospective cohort study.
Syringe is closely connected to Harm reduction in his research, which is encompassed under the umbrella topic of Odds ratio. The Cohort study combines topics in areas such as Gee, Incidence, Viral load, Emergency medicine and Risk factor. Thomas Kerr has researched Public health in several fields, including Law enforcement, SAFER, Family medicine and Environmental health.
Thomas Kerr spends much of his time researching Odds ratio, Prospective cohort study, Demography, Confidence interval and Harm reduction. His Odds ratio research focuses on subjects like Cohort, which are linked to Sexual violence. His Prospective cohort study research integrates issues from Cohort study, Heroin, Family medicine, Proportional hazards model and Hazard ratio.
His research in Family medicine intersects with topics in Health care, Substance abuse and Acquired immunodeficiency syndrome. His Harm reduction study combines topics in areas such as Psychological intervention, Syringe, Environmental health, Criminology and Drug. His study focuses on the intersection of Drug and fields such as Opioid overdose with connections in the field of Psychiatry.
Thomas Kerr mainly investigates Harm reduction, Confidence interval, Odds ratio, Demography and Prospective cohort study. His Harm reduction study integrates concerns from other disciplines, such as Criminology, Criminalization, Drug and Environmental health. He has included themes like Gee, Methadone, Opioid use disorder, Odds and Emergency medicine in his Odds ratio study.
He combines subjects such as Cannabis, Naloxone and Cohort with his study of Demography. His Prospective cohort study research is multidisciplinary, incorporating perspectives in Proportional hazards model and Hazard ratio. His Social policy research is multidisciplinary, incorporating elements of Psychological intervention and Public health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip.
The Lancet (2010)
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
Julio S. G. Montaner;Robert Hogg;Evan Wood;Thomas Kerr.
The Lancet (2006)
Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work
Kate Shannon;Thomas Kerr;Shari Allinott;Jill Chettiar.
Social Science & Medicine (2008)
Public health and international drug policy
Joanne Csete;Adeeba Kamarulzaman;Michel Kazatchkine;Frederick Altice.
The Lancet (2016)
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
Evan Wood;Thomas Kerr;Brandon D L Marshall;Kathy Li.
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Brandon D. L. Marshall;M.-J. Milloy;Evan Wood;Julio S. G. Montaner.
The Lancet (2011)
Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers.
Kate Shannon;Thomas Kerr;Steffanie A. Strathdee;Jean Shoveller.
The public health and social impacts of drug market enforcement: A review of the evidence
Thomas Kerr;Thomas Kerr;Will Small;Evan Wood;Evan Wood.
International Journal of Drug Policy (2005)
Structural and Environmental Barriers to Condom Use Negotiation With Clients Among Female Sex Workers: Implications for HIV-Prevention Strategies and Policy
Kate Shannon;Steffanie A. Strathdee;Jean Shoveller;Melanie Rusch.
American Journal of Public Health (2009)
Safer injection facility use and syringe sharing in injection drug users
Thomas Kerr;Thomas Kerr;Mark Tyndall;Mark Tyndall;Kathy Li;Kathy Li;Julio Montaner;Julio Montaner.
The Lancet (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: